tesa Labtec GmbH
Raiffeisenstr. 4
Langenfeld
40764
Germany
Tel: 49-2173-9735-0
Fax: 49-2173-9735-35
Website: http://www.labtec-pharma.com/
Email: info@labtec-pharma.com
15 articles about tesa Labtec GmbH
-
tesa Labtec Announces Local Representative in the United States
2/13/2019
The German based contract developer and contract manufacturer for transdermal patches and oral films moves closer to their customers and partners in the United States.
-
tesa Labtec GmbH Offers New Licensing Opportunity: Ropivacaine Transdermal Patch For The Treatment Of Neuropathic Pain
5/9/2017
-
tesa Labtec GmbH Announces Successful Completion Of FDA Pre-Approval Inspections Of Its R&D And Manufacturing Facilities
2/24/2016
-
tesa Labtec GmbH Opens U.S. Office
5/11/2015
-
tesa Labtec GmbH Attends 2014 AAPS Annual Meeting And Exposition
10/21/2014
-
New Name for Labtec GmbH
2/1/2013
-
APR Applied Pharma Research S.A. and Labtec GmbH Announce the European Approval of Zolmitriptan Oral Dispersible Film (ODF)
3/1/2012
-
APR Applied Pharma Research S.A., Labtec GmbH and Norgine Announce the Signature of an Exclusive Licensing Agreement Under Which Norgine will Market and Distribute Setofilm™
1/18/2012
-
APR Applied Pharma Research S.A. and Labtec GmbH Announce Ondansetron Oral Dispersible Film (“ODF”) is Now Available for Licensing in Europe and Selected Non European ountries, after Having Received Marketing Authorization in Most Countries of Europe
6/13/2011
-
Labtec GmbH Opens Europe’s Most Modern GMP Manufacturing Facility for Transdermal Patches and Oral Films
5/25/2011
-
APR Applied Pharma Research S.A. and Labtec GmbH Announce Filing for Approval in Europe of Zolmitriptan Oral Dispersible Film (ODF)
12/2/2010
-
Labtec GmbH's Sufentanil Patch for Chronic Pain Enters Phase II in Cooperation With Hameln Pharmaceuticals gmbh
11/1/2010
-
APR Applied Pharma Research S.A. and Labtec GmbH Enter Into Exclusive Licensing Agreement With Ferrer Internacional for the Registration and Marketing of Donepezil Oral Dispersible Film in Spain, Portugal and Germany
10/1/2010
-
APR Applied Pharma Research S.A. and Labtec GmbH Announce the Successful Completion of the Pivotal Clinical Study on Zolmitriptan RapidFilm(R), and Its Upcoming Submission for Registration in Europe
9/15/2010
-
Labtec GmbH and GlaxoSmithKline Finalize License Agreement
6/21/2010